Danish pharmaceutical giant Novo Nordisk, the world's largest producer of insulin, disclosed a data breach affecting patient information from some clinical trials. [...]

Source: BleepingComputer — read the full report at the original publisher.

This is a curated wire item. The Continuum Brief does not republish full third-party articles; this entry links to the original source.